[1] |
MEHDIZADEH GOHARI I, A NAVARRO M, LI J, et al. Pathogenicity and virulence of Clostridium perfringens[J]. Virulence, 2021, 12(1):723-753.
|
[2] |
GRENDA T, JAROSZ A, SAPAŁA M, et al. Clostridium perfringens-opportunistic foodborne pathogen,its diversity and epidemiological significance[J]. Pathogens, 2023, 12(6):768.
|
[3] |
HEIDA F H, VAN ZOONEN A G J F, HULSCHER J B F, et al. A necrotizing enterocolitis-associated gut microbiota is present in the meconium:results of a prospective study[J]. Clin Infect Dis, 2016, 62(7):863-870.
|
[4] |
VAN BUNDEREN C C, BOMERS M K, WESDORP E, et al. Clostridium perfringens septicaemia with massive intravascular haemolysis:a case report and review of the literature[J]. Neth J Med, 2010, 68(9):343-346.
|
[5] |
YANG Z, HU J, QU Y, et al. Interventions for treating gas gangrene[J]. Cochrane Database Syst Rev, 2015, 2015(12):CD010577.
|
[6] |
GIBERT M, JOLIVET-REYNAUD C, POPOFF M R. Beta2 toxin,a novel toxin produced by Clostridium perfringens[J]. Gene, 1997, 203(1):65-73.
|
[7] |
CAI J, SCHWARZ S, CHI D, et al. Faecal carriage of optrA-positive enterococci in asymptomatic healthy humans in Hangzhou,China[J]. Clin Microbiol Infect, 2019, 25(5):630.
|
[8] |
Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement[S]. M100-S18,CLSI, 2008.
|
[9] |
Clinical Laboratory Standards Institute. Methods for antimicrobial susceptibility testing of anaerobic bacteria[S]. M11-Ed9,CLSI, 2018.
|
[10] |
ROOD J I, ADAMS V, LACEY J, et al. Expansion of the Clostridium perfringens toxin-based typing scheme[J]. Anaerobe, 2018, 53:5-10.
DOI
PMID
|
[11] |
BHATTACHARYA A, SHANTIKUMAR S, BEAUFOY D, et al. Outbreak of Clostridium perfringens food poisoning linked to leeks in cheese sauce:an unusual source[J]. Epidemiol Infect, 2020, 148:e43.
|
[12] |
CARMAN R J, SAYEED S, LI J, et al. Clostridium perfringens toxin genotypes in the feces of healthy North Americans[J]. Anaerobe, 2008, 14(2):102-108.
|
[13] |
YADAV J P, KAUR S, DHAKA P, et al. Prevalence,molecular characterization,and antimicrobial resistance profile of Clostridium perfringens from India:a scoping review[J]. Anaerobe, 2022, 77:102639.
|
[14] |
HEINZE K, KABETO M, MARTIN E T, et al. Predictors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci co-colonization among nursing facility patients[J]. Am J Infect Control, 2019, 47(4):415-420.
|
[15] |
HUANG C, FENG S, HUO F, et al. Effects of four antibiotics on the diversity of the intestinal microbiota[J]. Microbiol Spectr, 2022, 10(2):e0190421.
|
[16] |
NG K M, FERREYRA J A, HIGGINBOTTOM S K, et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens[J]. Nature, 2013, 502(7469):96-99.
|
[17] |
WANG Y H. Sialidases from Clostridium perfringens and their inhibitors[J]. Front Cell Infect Microbiol, 2020, 9:462.
|
[18] |
MANTZARLIS K, MAKRIS D, ZAKYNTHINOS E. Risk factors for the first episode of Acinetobacter baumannii resistant to colistin infection and outcome in critically ill patients[J]. J Med Microbiol, 2020, 69(1):35-40.
|
[19] |
EIMER J, FRÉCHET-JACHYM M, LE DÛ D, et al. Association between increased linezolid plasma concentrations and the development of severe toxicity in multidrug-resistant tuberculosis treatment[J]. Clin Infect Dis, 2023, 76(3):e947-e956.
|
[20] |
GARVEYM. Foodborne clostridioides species:pathogenicity,virulence and biocontrol options[J]. Microorganisms, 2023, 11(10):2483.
|
[21] |
UZAL F A, NAVARRO M A, ASIN J, et al. Clostridial diarrheas in piglets:a review[J]. Vet Microbiol, 2023, 280:109691.
|
[22] |
LI J, ZHOU Y, YANG D, et al. Prevalence and antimicrobial susceptibility of Clostridium perfringens in chickens and pigs from Beijing and Shanxi,China[J]. Vet Microbiol, 2020, 252:108932.
|
[23] |
LENCER W I. Everything illuminated-Clostridium perfringens β-toxin[J]. Cell Host Microbe, 2020, 28(1):5-6.
|
[24] |
CAMARGO A, RAMÍREZ J D, KIU R, et al. Unveiling the pathogenic mechanisms of Clostridium perfringens toxins and virulence factors[J]. Emerg Microbes Infect, 2024, 13,(1):2341968.
|
[25] |
TOOTH D, GARSED K, SINGH G, et al. Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea:origin and effect of gut transit[J]. Gut, 2014, 63(5):753-760.
|
[26] |
FOHLER S, KLEIN G, HOEDEMAKER M, et al. Diversity of Clostridium perfringens toxin-genotypes from dairy farms[J]. BMC Microbiol, 2016, 16(1):199.
|
[27] |
XIU L, LIU Y, WU W, et al. Prevalence and multilocus sequence typing of Clostridium perfringens isolated from 4 duck farms in Shandong province,China[J]. Poult Sci, 2020, 99(10):5105-5117.
|
[28] |
李红新, 卢迎瑞, 张爽, 等. 北京市顺义区87名健康人中产气荚膜梭菌携带特征研究[J]. 中国食品卫生杂志, 2019, 31(1):13-16.
|
[29] |
WANG B, DONG W, MA L, et al. Prevalence and genetic diversity of Clostridium perfringens isolates in hospitalized diarrheal patients from central China[J]. Infect Drug Resist, 2021, 14:4783-4793.
|
[30] |
BALKAN I I, AYGÜN G, AYDIN S, et al. Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae:treatment and survival[J]. Int J Infect Dis, 2014, 26:51-56.
|